ANN

MarketMind Technologies Unveils Beta Launch of GenAI Investor Relations Platform to Service the Increase in Retail Investors Growth

Retrieved on: 
пятница, мая 31, 2024
Cloud, Toronto Stock Exchange, API, Risk, Engineering, Google Cloud, AI, ANN, RAG, Social media, LLM, Cryptocurrency

Toronto, Canada, May 31, 2024 (GLOBE NEWSWIRE) -- MarketMind Technologies Inc. unveiled a generative AI investor relations platform.

Key Points: 
  • Toronto, Canada, May 31, 2024 (GLOBE NEWSWIRE) -- MarketMind Technologies Inc. unveiled a generative AI investor relations platform.
  • Marketmind is backed by Alpha Transform Holdings, a prolific investor and advisor in financial technology and digital assets.
  • Engineering development for the platform comes from Cloudbench , a Google Cloud Partner specializing in AI and web3 technologies, utilizing its joint Frisco-based AI Foundry with Arhasi.
  • “The MarketMind AI IR platform offers companies a superior alternative for market messaging and investor guidance.

Esperion to Participate in Upcoming June Investor Conferences

Retrieved on: 
четверг, мая 23, 2024
Conference, Patient, Esperies, ESPR, ANN, Health, Risk

ANN ARBOR, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of May, which can be found on our investor relations website .

Key Points: 
  • ANN ARBOR, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of May, which can be found on our investor relations website .
  • Jefferies Global Healthcare Conference in New York on June 5, 2024, at 4:30 p.m.
  • Live webcasts can be accessed on the investor and media section of the Esperion website .
  • At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases.

Washtenaw Community College named national 2024-2025 Military Friendly® School

Retrieved on: 
среда, мая 22, 2024
Employment, Methodology, WCC, Education, Heart, University, Engineering, Dream, School, ANN, Student, Veteran, U-M, Tier 1, Michigan Veterans Affairs Agency, Washtenaw Community College, Nursing

ANN ARBOR, Mich., May 22, 2024 (GLOBE NEWSWIRE) -- Washtenaw Community College (WCC) has earned the national 2024-2025 Military Friendly® Schools designation for its support of nearly 500 veteran students and their families.

Key Points: 
  • ANN ARBOR, Mich., May 22, 2024 (GLOBE NEWSWIRE) -- Washtenaw Community College (WCC) has earned the national 2024-2025 Military Friendly® Schools designation for its support of nearly 500 veteran students and their families.
  • For six consecutive years, WCC has been named as a Gold-level Veteran-Friendly School by the Michigan Veterans Affairs Agency.
  • Viqtory is a service-disabled, veteran-owned small business that connects the military community to civilian employment, educational and entrepreneurial opportunities.
  • Schools who achieve awards designation show true commitment in their efforts, going over and above that standard,” said Kayla Lopez, National Director of Military Partnerships, Military Friendly®.

Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia

Retrieved on: 
понедельник, мая 20, 2024
LDL, Patient, ATP, Hypercholesterolemia, Esperion Therapeutics, Liver, Therapy, ESPR, Safety, Week, ANN, Adenosine triphosphate, Pharmaceutical industry

The trial demonstrated statistically significant outcomes on the primary endpoint for bempedoic acid and highlighted its potential future value to patients in Japan.

Key Points: 
  • The trial demonstrated statistically significant outcomes on the primary endpoint for bempedoic acid and highlighted its potential future value to patients in Japan.
  • Bempedoic acid is marketed for the treatment of hypercholesterolemia and cardiovascular risk reduction in several regions of the world, including the United States and Europe.
  • In 2020, Otsuka acquired exclusive development and commercialization rights for bempedoic acid in Japan from Esperion and is currently developing it domestically.
  • Trial participants were administered either 180 mg of bempedoic acid or a placebo, orally, once a day, for 12 weeks to evaluate the efficacy and safety of bempedoic acid.

Kraig Biocraft Laboratories Spring Spider Silk Production Trials Exceed Expectations

Retrieved on: 
четверг, мая 9, 2024
ANN, KBLB, Health, Disease, Breeding, News, Silk, Dragon silk, Infection, Observation, OTCQB

ANN ARBOR, Mich., May 09, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that the spring production trials of the Company's new BAM-1 hybrid parental strains have concluded, exceeding all expectations for scale, performance and robustness.

Key Points: 
  • ANN ARBOR, Mich., May 09, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that the spring production trials of the Company's new BAM-1 hybrid parental strains have concluded, exceeding all expectations for scale, performance and robustness.
  • Kraig Labs reports that the spring production trials were an unabashed success.
  • These trials proved that the Company's BAM-1 recombinant spider silk hybrids are ready for rapid production expansion.
  • Thompson is now returning to the U.S. to enact the next stages of its spider silk production expansion plan and complete the Company's transition from a technology developer to a large-scale spider silk manufacturer.

Blackwell Security raises $13M co-led by General Catalyst and Rally Ventures to empower healthcare cybersecurity operations

Retrieved on: 
вторник, мая 7, 2024
HIPAA, Internet of things, ANN, Survival, Intelligence, PPE, Health, CIO, RSA, Growth, Pulse, Medical device

ANN ARBOR, Mich., May 07, 2024 (GLOBE NEWSWIRE) -- Blackwell Security , a provider of specialized cybersecurity solutions tailored for the healthcare sector, announced today a $13M round of funding co-led by General Catalyst and Rally Ventures to help bolster security operations in healthcare.

Key Points: 
  • ANN ARBOR, Mich., May 07, 2024 (GLOBE NEWSWIRE) -- Blackwell Security , a provider of specialized cybersecurity solutions tailored for the healthcare sector, announced today a $13M round of funding co-led by General Catalyst and Rally Ventures to help bolster security operations in healthcare.
  • Equipped with HIPAA compliance, they have the ability to enhance security operations in healthcare delivery and healthcare assurance settings.
  • As part of today’s announcement, Blackwell has appointed cyber security expert and business leader Geyer Jones as their first Chief Executive Officer.
  • “It's a privilege to join Blackwell Security and collaborate with General Catalyst and Rally Ventures in tackling the significant challenges of healthcare cybersecurity,” said Jones.

SARC LAUNCHES GLOBAL SARCOMA CENTERS REGISTRY SUPPORTING PATIENT AND CLINICIAN ACCESS TO PROGRAMS EXPERT IN THE DIAGNOSIS AND TREATMENT OF SARCOMA (RARE AND ULTRARARE CANCER TYPES COMPRISING 15-20% OF CHILDHOOD CANCERS AND 1% OF ADULT CANCERS)

Retrieved on: 
среда, мая 8, 2024
ANN, Diagnosis, Cancer, Patient, Sarcoma, SARC, Caregiver

ANN ARBOR, Mich., May 8, 2024 /PRNewswire/ -- SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce the launch of the Sarcoma Centers Registry https://sarctrials.org/sarcoma-centers/, a comprehensive, global resource facilitating informed patient decision-making via access to specialized clinical programs expert in the diagnosis and treatment of sarcoma.

Key Points: 
  • ANN ARBOR, Mich., May 8, 2024 /PRNewswire/ -- SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce the launch of the Sarcoma Centers Registry https://sarctrials.org/sarcoma-centers/ , a comprehensive, global resource facilitating informed patient decision-making via access to specialized clinical programs expert in the diagnosis and treatment of sarcoma.
  • SARC has today launched a new resource for patients to streamline access to expert sarcoma centers worldwide.
  • Sarcoma is a rare and heterogeneous group of cancers of connective tissues that comprise nearly 20% of childhood cancers and 1% of adult cancers.
  • With dozens of sarcoma programs already accepted, SARC invites all sarcoma programs from around the globe to apply for listing— https://sarctrials.org/apply/ .

Upkara seeks partnerships for breakthrough biomolecule stabilization technology under leadership of new CEO

Retrieved on: 
среда, мая 8, 2024
ANN, CMV, Freezing, Enzyme, Antibody, Dicarboxylic acid, Water, Fine chemical

The novel stabilization technology , called capillary-mediated vitrification (CMV), quickly evaporates water from samples without the freezing step that makes lyophilization expensive, time consuming, and results in reduced product yields.

Key Points: 
  • The novel stabilization technology , called capillary-mediated vitrification (CMV), quickly evaporates water from samples without the freezing step that makes lyophilization expensive, time consuming, and results in reduced product yields.
  • The technology streamlines product development and manufacturing, reduces supply chain risks, curtails expenses, expands market access, and improves sustainability.
  • Upkara offers licensing of their stabilization technology to commercial reagent and kit manufacturers for integration onto manufacturing lines, or customers can contract Upkara to provide stabilization services.
  • "I'm tremendously excited to engage with partners across the biotechnology industry to demonstrate the transformative potential of our stabilization technology on manufacturing lines," says new CEO, Rich Troyer.

Genomenon Acquires The Jackson Laboratory's Clinical Knowledgebase (CKB) to Fuel its Mission to Curate the Human Genome

Retrieved on: 
среда, мая 8, 2024
Cancer, Genomics, Jackson Laboratory, ANN, CKB, JAX, Acquisition, Mouse, Database, Genome, Medicine, Growth, Antibiotics

ANN ARBOR, Mich., May 8, 2024 /PRNewswire-PRWeb/ -- Genomenon, a genomic intelligence company today announced its acquisition of the Clinical Knowledgebase (CKB) from The Jackson Laboratory (JAX). CKB is the leading curated variant database used for interpreting complex cancer genomic profiles by some of the world's premier oncology labs. This strategic acquisition enables Genomenon to provide an unprecedented understanding of the genome, with insights now covering both germline and somatic variants, furthering its lead in the race to curate the genome. Financial terms of the acquisition were not disclosed.

Key Points: 
  • This strategic acquisition enables Genomenon to provide an unprecedented understanding of the genome, with insights now covering both germline and somatic variants, furthering its lead in the race to curate the genome.
  • "The acquisition of CKB is a significant step in Genomenon's mission to curate the entire human genome," shared Mike Klein, CEO of Genomenon.
  • "The acquisition of CKB is a significant step in Genomenon's mission to curate the entire human genome," shared Mike Klein, CEO of Genomenon.
  • In June 2023, Genomenon announced the acquisition of Boston Genetics as part of its mission to curate the human genome.

Censys Launches the Censys Integrations Marketplace to Improve Security Teams Efficiency

Retrieved on: 
вторник, мая 7, 2024
ANN, RSA Conference, Risk, Conference, Marketplace

ANN ARBOR, Mich., May 7, 2024 /PRNewswire/ -- Censys, the leading Internet Intelligence Platform for Threat Hunting and Attack Surface Management, today at the RSA Conference, announced the Censys Integrations Marketplace, which allows security teams to onboard any integration with any vendor, in the marketplace, in less than 15 minutes. The Censys Integrations Marketplace revolutionizes the entire process, delivering a streamlined and automated security ecosystem in one place.

Key Points: 
  • The Censys Integrations Marketplace revolutionizes the entire process, delivering a streamlined and automated security ecosystem in one place.
  • The Censys Integrations Marketplace addresses these concerns by providing better visibility into threats and allows customers to deploy new solutions faster than ever before," says Brad Brooks, CEO of Censys.
  • The Censys Integrations Marketplace currently offers 14 tailored integrations with specific vendors, including both security and non-security solutions, making it the first marketplace to extend beyond the traditional security ecosystem.
  • Supported by Censys' Rapid Integrations program, customers will be able to request new integrations that can be added to the Marketplace in weeks.